BioSpace News Archive

Genetown

OvaScience to Present at Upcoming 2012 Investor Conferences

September 7, 2012
·
1 min read
Drug Development

InSite Vision Fully Enrolls Phase 3 DOUBle Clinical Study of AzaSite Plus and DexaSite for Blepharitis

September 7, 2012
·
1 min read
Genetown

Advanced Cell Technology to Present at 14th Annual Rodman & Renshaw Global Investment Conference

September 7, 2012
·
1 min read
Proton Pharma and Rottapharm Switch to Cloud-Based Veeva Systems, Inc. CRM for its Flexibility to Meet Unique Local Needs in Greece

September 7, 2012
·
4 min read
Genetown

Verastem, Inc. to Present on Focal Adhesion Kinase Program at the 11th International Conference of the International Mesothelioma Interest Group

September 7, 2012
·
1 min read
Drug Development

Trillium Therapeutics Inc.'s Anti-CD47 Oncology Program Highlighted in Prestigious Journal

September 7, 2012
·
2 min read
Genetown

New CardioFocus Inc. HeartLight$0174 Data Reinforces Impressive Single Procedure Chronic Success Rates in the Treatment of Atrial Fibrillation

September 7, 2012
·
4 min read
Genetown

Boston Scientific Corporation to Participate in the 2012 Morgan Stanley Global Healthcare Conference

September 7, 2012
·
1 min read
Biotech Beach

CytRx Corporation’s Aldoxorubicin Clinical Data Selected for Presentation at Preeminent Sarcoma Conference

September 7, 2012
·
1 min read
Drug Development

Dompé: The First International Clinical Ophthalmological Trial Concerning Treatment of Neurotrophic Keratitis (NK), an Ocular Pathology With No Cure, Takes Place in Italy

September 7, 2012
·
1 min read